The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Spatially organized immune niches in high-grade primary prostate cancer.
 
Aishwarya Atmakuri
No Relationships to Disclose
 
Robert Serafin
No Relationships to Disclose
 
Jeremiah Wala
Stock and Other Ownership Interests - nference
 
Ali Amiryousefi
No Relationships to Disclose
 
Jia-Ren Lin
No Relationships to Disclose
 
Brian Labadie
No Relationships to Disclose
 
Kiranj Chaudagar
No Relationships to Disclose
 
Madeleine Torcasso
No Relationships to Disclose
 
Peter Sorger
Leadership - Flagship Pioneering; Glencoe Software; RareCyte
Stock and Other Ownership Interests - Glencoe Software; Montai Health; RareCyte
Honoraria - Novartis
Consulting or Advisory Role - Merck
Research Funding - Merck (Inst)
 
Akash Patnaik
Stock and Other Ownership Interests - Gilead Sciences; Infinity Pharmaceuticals; Merck; Merck
Honoraria - BostonGene; Medscape; Prime Oncology
Consulting or Advisory Role - AstraZeneca; Curio Science; Exelixis; Gerson Lehrman Group; Guidepoint Pharmacy; Johnson & Johnson/Janssen; Novartis
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Exelixis (Inst); Laekna Health Care (Inst); Progenics (Inst); Xencor (Inst); Zenith Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Exelixis; Prime Oncology